US Stock Movement | Vertex Pharmaceuticals (VRTX.US) surges after hours as late-stage trial of kidney drug povetacicept meets expected targets
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Previously, this biotechnology company announced that its drug for treating kidney disease met the expected targets in late-stage trials, injecting momentum into its strategy to go beyond cystic fibrosis treatments. As of Monday's close, the company's stock price has risen 1.7% so far this year.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Spackman Equities refiles 2025 annual filings with corrective disclosure after OSC review
Reuters•2026/08/08 00:53
Pacific Empire Minerals grants 17,700,000 stock options, 6,800,000 RSUs at C$ 0.05
Reuters•2026/08/08 00:52
Avarga FY26 H1 net profit rises to S$21.69 million; revenue falls 9% to S$719.01 million
Reuters•2026/08/08 00:51
Taiga Building Products Q2 net sales fall 3% to CAD 426.6 million on lower commodity prices
Reuters•2026/08/08 00:49
Crypto prices
MoreBitcoin
BTC
$64,874.52
+0.96%
Ethereum
ETH
$1,913.28
+0.67%
Tether USDt
USDT
$0.9994
+0.04%
USDC
USDC
$0.9999
+0.01%
XRP
XRP
$1.02
-1.04%
Solana
SOL
$73.64
+1.48%
TRON
TRX
$0.3275
+0.22%
Hyperliquid
HYPE
$53.98
-3.28%
Dogecoin
DOGE
$0.06977
+0.86%
Zcash
ZEC
$507.24
+0.45%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now